Darshan Patel, MD
Hand Surgery · Houston, TXNPI 1306264916
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,275 of the $11,815 with a category attached, or 61.6%. Skeletal Dynamics Inc accounts for 82.6% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $8,477, more than ten times the $541 reported in 2020.
Across 59 payments — averaging $200.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skeletal Dynamics Inc$10K
- Boston Scientific$713
- Trimed, Inc.$500
- Stryker$182
- Endo USA, Inc.$130
- Smith+Nephew$116
- plus $414 from 10 others
What the payments were for
- Travel & lodging$2,34120%
- Food & beverage$2,19919%
- Education$7,27562%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skeletal Dynamics Inc | 13 | $9,760 |
| Boston Scientific | 26 | $713 |
| Trimed, Inc. | 1 | $500 |
| Stryker | 2 | $182 |
| Endo USA, Inc. | 1 | $130 |
| Smith+Nephew | 4 | $116 |
| Axogen | 1 | $79 |
| Align Technology, Inc. | 1 | $75 |
| Neurelis, Inc. | 3 | $52 |
| Johnson & Johnson | 1 | $47 |
| Medinc Of Texas | 1 | $47 |
| Arthrosurface Incorporated | 1 | $34 |
| Sioux Surgical Inc | 1 | $29 |
| Trice Medical, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,815 in reported general payments places this provider in the 75th percentile of 170 hand surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 129 | $648 |
| Cyclobenzaprine Hcl | 36 | $142 |
| Meloxicam | 77 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Houston
- Kourosh JafarniaHouston$278K
- Adil AhmedHouston$30K
- Andrea TianHouston$26K
- Kyle WoernerHouston$18K
- Adam SharHouston$16K
- Scott MitchellHouston$12K
- Ashton MansourHouston$11K
- Mark KhorsandiHouston$10K
- James BennettHouston$10K
- Randy LuoHouston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.